PEBP1 Knockout HEK293 Cell Line

PEBP1 Knockout HEK293 Cell Line
Cat.No.:

EDC07757

Species:

Human

Cell Name:

HEK293

Gene:

PEBP1

Gene ID:

5037

Size:

1×10⁶cells

PEBP1 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
Cat.No. EDC07757
Product Name PEBP1 Knockout Cell Line (HEK293)
Cell Line HEK293
Cellosaurus ID CVCL_0045
Cell Line Synonyms Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293
Gene PEBP1
NCBI Gene ID
Gene Synonyms HCNP|HCNPpp|HEL-210|HEL-S-34|HEL-S-96|PBP|PEBP|PEBP-1|RKIP
Summary
This gene encodes a member of the phosphatidylethanolamine-binding family of proteins and has been shown to modulate multiple signaling pathways, including the MAP kinase (MAPK), NF-kappa B, and glycogen synthase kinase-3 (GSK-3) signaling pathways. The encoded protein can be further processed to form a smaller cleavage product, hippocampal cholinergic neurostimulating peptide (HCNP), which may be involved in neural development. This gene has been implicated in numerous human cancers and may act as a metastasis suppressor gene. Multiple pseudogenes of this gene have been identified in the genome. [provided by RefSeq, Jul 2015]
Associated Diseases Non-tumor
Morphology Adherent
Passage Ratio 1/5,2days
Complete Culture Medium DMEM + 10% FBS
Freezing Medium 95% Complete culture medium+ 5% DMSO
QC Indels validated by Sanger sequencing; sterility confirmed via microbial testing.
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
LociSTR Info (Sample Cell)
Sample Cell Line: HEK293
STR Info (Cell bank)
Cell Line: HEK293
Allele1Allele2Allele1Allele2
Amelogenin X X
CSF1P0 12 11 12
D2S1338 19 19
D3S1358 15 17 15 17
D5S818 8 8 9
D7S820 11 12 11 12
D8S1179 12 14 12 14
D13S317 12 14 12 14
D16S539 9 13 9 13
D18S51 17 18 17 18
D19S433 15 18 15 18
D21S11 28 30.2 28 30.2
FGA 23 23
Penta D 9 10 9 10
Penta E 7 15 7 15
TH01 7 9.3 7 9.3
TPOX 11 11
vWA 16 19 16 19
D6S1043 11 11
D12S391 19 21 11 15
D2S441 11 15 11 15
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.

FAQ

The choice depends on whether you are studying PEBP1 (RKIP, Raf kinase inhibitor protein)'s role as a metastasis suppressor or its functions inhibiting Raf-MEK-ERK signaling and IKK/NF-κB pathways. The Knockout line is the standard tool for asking whether RKIP is required for these inhibitory functions — RKIP binds and inhibits Raf-1, MEK1, GRK2, and IKK, broadly attenuating proliferative and inflammatory signaling. Overexpression is useful for studying RKIP tumor suppressor functions in cancer contexts. For cancer biology research, the EDITGENE PEBP1 Knockout in HEK293 enables study of Raf-MEK-ERK and NF-κB pathway hyperactivation following RKIP loss. Rescue with wild-type or phospho-RKIP-mimetic (S153D, which switches RKIP from Raf inhibition to GRK2 inhibition) enables comprehensive structure-function studies. RKIP loss is associated with metastatic progression in multiple cancers — the knockout serves as a tool for studying metastasis-permissive signaling networks.
Primary applications: • Raf-MEK-ERK pathway: phospho-MEK1/2 and phospho-ERK1/2 analysis to assess RKIP-mediated MAPK pathway attenuation in the absence of RKIP. • NF-κB signaling: phospho-IKK, phospho-IκBα, and NF-κB target gene expression analysis given RKIP's IKK inhibition. • GRK2-mediated GPCR desensitization: β-adrenergic receptor desensitization kinetics given RKIP's role in switching from Raf to GRK2 inhibition following S153 phosphorylation. • Metastasis biology: invasion, migration, and EMT marker analysis given RKIP's role as a metastasis suppressor. EDITGENE recommends this model for researchers investigating RKIP-mediated signaling attenuation, metastasis suppression mechanisms, and MAPK/NF-κB pathway regulation.
Yes. RKIP rescue experiments are well-established for signaling research: • Construct design: use a codon-modified PEBP1 sequence with a small C- or N-terminal tag (FLAG, HA). RKIP is small (~21 kDa) cytoplasmic protein — both tag positions are typically tolerated. • Raf-binding-deficient rescue: specific residue mutations in the Raf-binding interface enable separating Raf inhibition from GRK2 inhibition. • Phospho-mimetic rescue: S153D mutation mimics PKC-phosphorylated RKIP, switching from Raf to GRK2 inhibition — invaluable for studying RKIP's dual regulation. • Functional readout: rescue should restore Raf-MEK-ERK pathway attenuation, NF-κB pathway inhibition, and metastasis suppressor phenotypes. HEK293 transduces efficiently with lentivirus and supports stable rescue line generation.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.

Required Accessories

Related Products

Flash CRISPR Knockout Kit(Universal Version)Flash CRISPR Knockout Kit(Universal Version)
Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)Flash-Pro CRISPR KO Kit (For Organoids / Stem Cells)

Related Services

Knockout Cell LineKnockout Cell Line
Contact Us
*
*
*
*
How did you hear about us: